Michael S. Cuffe's most recent trade in HCA Healthcare Inc was a trade of 9,628 Common Stock done . Disclosure was reported to the exchange on Feb. 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2026 | 9,628 | 35,580 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 502.05 per share. | 10 Feb 2026 | 3,501 | 32,079 (0%) | 0% | 502.0 | 1,757,677 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Feb 2026 | 4,050 | 25,952 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 498.09 per share. | 03 Feb 2026 | 1,500 | 30,002 (0%) | 0% | 498.1 | 747,135 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2026 | 8,067 | 8,067 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 173.12 per share. | 04 Sep 2025 | 10,920 | 42,422 (0%) | 0% | 173.1 | 1,890,470 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2025 | 10,920 | 10,000 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 411.59 per share. | 04 Sep 2025 | 7,084 | 35,338 (0%) | 0% | 411.6 | 2,915,704 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 418.84 per share. | 04 Sep 2025 | 3,836 | 31,502 (0%) | 0% | 418.8 | 1,606,670 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 2,330 | 32,008 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 321.92 per share. | 13 Feb 2025 | 583 | 31,425 (0%) | 0% | 321.9 | 187,679 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 11,171 | 11,171 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 22,080 | 0 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 145.24 per share. | 10 Sep 2024 | 22,080 | 51,758 (0%) | 0% | 145.2 | 3,206,899 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 386.43 per share. | 10 Sep 2024 | 13,722 | 38,036 (0%) | 0% | 386.4 | 5,302,592 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 385.42 per share. | 10 Sep 2024 | 8,358 | 29,678 (0%) | 0% | 385.4 | 3,221,340 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 316.88 per share. | 09 May 2024 | 6,311 | 29,623 (0%) | 0% | 316.9 | 1,999,825 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 18,660 | 0 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 139.06 per share. | 06 May 2024 | 18,660 | 52,783 (0%) | 0% | 139.1 | 2,594,860 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 314.45 per share. | 06 May 2024 | 12,349 | 40,434 (0%) | 0% | 314.4 | 3,883,143 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 06 May 2024 | 4,500 | 35,934 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 309.00 per share. | 06 May 2024 | 1,600 | 34,123 (0%) | 0% | 309 | 494,400 | Common Stock |
| HCA Healthcare | Cuffe Michael S. | EVP and Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 12,560 | 37,488 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | S. Michael Cuffe | EVP and Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 308.55 per share. | 16 Feb 2024 | 6,212 | 35,696 (0%) | 0% | 308.6 | 1,916,713 | Common Stock |
| HCA Healthcare | S. Cuffe Michael | EVP and Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 4,420 | 41,908 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Cuffe Michael S. | EVP and Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 12,656 | 12,656 | - | - | Stock Appreciation Right | |
| HCA Healthcare | S. Michael Cuffe | EVP and Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 306.79 per share. | 31 Jan 2024 | 3,200 | 24,928 (0%) | 0% | 306.8 | 981,734 | Common Stock |
| HCA Healthcare | S. Cuffe Michael | EVP and Chief Clinical Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Jan 2024 | 728 | 28,128 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 284.44 per share. | 28 Apr 2023 | 12,556 | 28,783 (0%) | 0% | 284.4 | 3,571,396 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.16 per share. | 24 Apr 2023 | 32,020 | 60,803 (0%) | 0% | 101.2 | 3,239,143 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Apr 2023 | 32,020 | 0 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 286.25 per share. | 24 Apr 2023 | 19,464 | 41,339 (0%) | 0% | 286.3 | 5,571,570 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 12,160 | 32,982 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 262.84 per share. | 17 Feb 2023 | 4,232 | 28,750 (0%) | 0% | 262.8 | 1,112,339 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 14,524 | 14,524 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 257.11 per share. | 30 Jan 2023 | 4,000 | 20,822 (0%) | 0% | 257.1 | 1,028,440 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jan 2023 | 450 | 24,822 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 10,840 | 28,801 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.10 per share. | 18 Feb 2022 | 3,658 | 25,143 (0%) | 0% | 244.1 | 892,918 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | EVP and Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 15,250 | 15,250 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Michael S. Cuffe | President-Physician Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2021 | 7,350 | 7,350 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Michael S. Cuffe | President-Physician Services | Sale of securities on an exchange or to another person at price $ 251.91 per share. | 03 Aug 2021 | 2,500 | 17,914 (0%) | 0% | 251.9 | 629,775 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | President-Physician Services | Sale of securities on an exchange or to another person at price $ 201.53 per share. | 29 Apr 2021 | 18,664 | 20,369 (0%) | 0% | 201.5 | 3,761,384 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | President-Physician Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 5,930 | 0 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Michael S. Cuffe | President-Physician Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 81.96 per share. | 29 Apr 2021 | 5,930 | 42,827 (0%) | 0% | 82.0 | 486,023 | Common Stock |
| HCA Healthcare | Michael S. Cuffe | President-Physician Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 201.94 per share. | 29 Apr 2021 | 3,794 | 39,033 (0%) | 0% | 201.9 | 766,160 | Common Stock |